Strados Labs

10/13/2025

We are excited to be attending and sponsoring HLTH USA next week from October 19-22 in Las Vegas!

Come visit Strados Labs in the Science Center Pavilion (2562, Level 2 of the Exhibit Hall) to learn how we’re transforming respiratory surveillance and care from hospital to home.

Our CEO & Founder, Nick Delmonico and Marketing Manager, Gabe Steerman, will be onsite throughout the event.

Please message Nick to schedule a meeting, or stop by our kiosk to connect in person!

10/09/2025

We were thrilled to present two abstracts at ERS Congress last week, where our Director of Data Science, Tom deLaubenfels, PhD, shared new research on objectively quantifying the burden of cough bouts using the RESP® Biosensor.

In this presentation, Dr. deLaubenfels shares how cough intensity, captured continuously during real-world recordings, may provide deeper insight into cough severity and disease impact across subacute and chronic cough populations.

This work was part of two new posters presented at ERS 2025:

- Objectively Quantifying the Burden of Cough Bouts in Chronic and Subacute Cough
- Automated Cough Identification in Chronic Cough from Real-World Recordings by a Custom Machine Learning Algorithm

🔗 Digital versions of both posters are now available: view them here!
https://bit.ly/3KF8PPP
https://bit.ly/4ogzjpw

10/03/2025

Decentralized Clinical Trials (DCTs) are transforming data collection, expanding access, increasing data frequency, and reducing patient burden. But they bring challenges: multiple data sources, device variability, integration complexity, and strict privacy rules.

A recent Fierce Biotech article outlines key strategies: pre-trial tool validation, real-time monitoring, standardized collection, and strong data management. Success in DCTs demands more than tech. It requires solid infrastructure, regulatory alignment, and expert partners: https://bit.ly/3Jerzoz

At Strados Labs, our RESP® Biosensor and cloud platform are built for decentralized and hybrid trials, securely capturing continuous, high-fidelity lung sound recordings in real-world settings. We help sponsors improve data quality, minimize gaps, detect changes earlier, and meet global privacy standards.

As DCTs become the norm, respiratory endpoints deserve the same rigor as any other measure. We make sure they get it.

1. Introduction | Decentralized Clinical Trials (DCTs) are transforming how we collect clinical data, but this evolution brings unprecedented challenges in data quality, complexity, and integration.

09/25/2025

Today on World Lung Day, we’re reminded that healthy lungs are essential for healthy lives.

Respiratory diseases like asthma, COPD, pulmonary fibrosis, and bronchiectasis affect millions worldwide. Lung sounds such as cough, wheeze, and crackles are more than symptoms: they’re signals clinicians use to understand disease burden and patient health.

Across healthcare and research, new innovations are helping us continuously measure and monitor these signals, allowing for earlier interventions and better outcomes. At Strados Labs, we’re proud to be part of this movement to advance respiratory health.

On World Lung Day, we stand with patients, caregivers, and researchers working to protect and improve lung health everywhere.

09/24/2025

🫁 ERS is almost here!

In just a few days, thousands of respiratory professionals will gather in Amsterdam and online to share new science, exchange ideas, and shape the future of care.

Here’s where to find Strados Labs during the Congress:

• Exhibit Hall: Hall A, Booth 11: Open Sun, Sept 28 - Tues, Sept 30. Stop by to hear our latest updates and learn how the RESP Biosensor can enable novels insights into your patients' respiratory status
• Poster Presentations: Two posters in the Chronic Cough Poster Session (Session 46, PS-17) on Sunday, Sept 28, 8:00–9:30 a.m., exploring innovative ways to measure cough burden and apply machine learning.
• Award Sponsorship: On Tuesday, Sept 30, we’re honored to sponsor the ERS Grant for Best Abstract in Symptoms and Quality of Life in ILD (5:15–6:35 p.m., Room Elicium 2).

We look forward to connecting with clinicians, researchers, and partners working to advance respiratory health.

See you in Amsterdam!

09/18/2025

We are proud to support research on Interstitial Lung Disease (ILD) at .

This year, Strados Labs is sponsoring the ERS Grant for Best Abstract in Symptoms and Quality of Life in ILD, which will be awarded on Tuesday, Sept 30, 5:15–6:35 p.m. in Room Elicium 2. The grant recognizes research that expands our understanding of ILD, particularly how symptoms are experienced by patients and how innovations in care can improve quality of life.

Supporting this grant reflects our mission at Strados Labs: advancing patient-centered research and empowering clinicians with real-world respiratory data to improve outcomes. We look forward to celebrating the researchers driving progress for people living with ILD.

09/09/2025

New evidence links symptoms to future bronchiectasis exacerbations 🫁

A recent analysis of data from the EMBARC - The European Bronchiectasis Network registry suggested that daily symptoms, like cough, are an independent risk factor for future exacerbations.

Patients with a high symptom burden but few prior exacerbations responded to long-term macrolide therapy just as well as those with frequent exacerbations.

This finding reinforces the role of cough in bronchiectasis, not only as a burden on quality of life, but also as a potential signal for exacerbations. Objective cough monitoring could allow clinicians to detect at-risk patients earlier and guide more informed treatment strategies.

Read more: https://www.sciencedirect.com/science/article/pii/S2213260025001602

09/04/2025

Strados Labs is headed to ERS 2025! 🌍

The European Respiratory Society Congress is one of the most significant global gatherings for respiratory professionals, bringing together researchers, clinicians, and industry leaders to share the latest advances in respiratory science and care. This year’s Congress takes place September 27th – October 1st in Amsterdam, and our team including Nick Delmonico, Shane Krauss and Tom deLaubenfels, is excited to participate once again!

We look forward to contributing to the conversation around chronic cough and real-world respiratory monitoring with new publications and in-person engagement in the exhibit hall. We are also proud to be sponsoring the ERS Grant for Best Abstract in Symptoms and Quality of Life in ILD.

Please stop by our booth in the exhibit hall at A.11 from Sept 28-30th to say hello. If you'd like to schedule a time to talk, book a meeting: https://meetings.hubspot.com/shane286/ers-2025

We look forward to seeing familiar faces and making new connections at !

08/26/2025

For over 200 years, the stethoscope has been the gold standard for listening to lung health. We asked: What if we could bring that same trusted sound quality into a wearable device--one that allows for continuous monitoring beyond the clinic?

In our latest blog, Jason Kroh, Chief Technology Officer, shares how we designed the RESP® Biosensor by blending the core principles of stethoscope auscultation with advanced signal processing, multiple sensor modalities, wireless transmission, and AI integration.

From capturing high-fidelity lung sounds to correlating them with movement, posture, and activity levels, the RESP Biosensor offers researchers and clinicians a powerful new way to monitor respiratory health in real-world settings.

Read the full blog post here: https://stradoslabs.com/from-stethoscope-to-sensor-how-we-developed-a-lung-acoustics-wearable/

08/19/2025

The 9th Annual IPF Summit starts tomorrow in Boston!

Over the next few days, experts from across the globe will explore how we can redefine therapeutic success in pulmonary fibrosis—addressing questions around disease modification, targeting TGFB safely, and even reversing fibrosis. https://ipf-summit.com/

Visit Strados Labs in the exhibit hall and learn how the RESP® Biosensor is advancing IPF clinical trials by providing novel insights into treatment effects, including cough reduction.

Welcome to the 9th IPF Summit 2025! Welcome To the Go-To Industry Forum for Pulmonary Fibrosis Professionals.

08/14/2025

The countdown is on for the 9th Annual IPF Summit next week in Boston, August 19–21.

This year’s agenda dives deep into the next generation of therapeutic development for pulmonary fibrosis, exploring fresh approaches in RNA therapies, antifibrotics, regenerative medicine, and more. With new efficacy readouts on the horizon, the field is poised for disruption.

As a proud sponsor and poster presenter at the IPF Summit, Strados Labs together with our Life Sciences Director, Shane Krauss, will highlight how the RESP® Biosensor enables clinical trial teams to gain deeper insights into the impact of IPF treatments on cough, a highly prevalent and burdensome symptom for people living with pulmonary fibrosis.

We look forward to connecting with industry leaders who share our mission to improve outcomes for those living with pulmonary fibrosis. Register here: https://ipf-summit.com/

08/12/2025

Can continuous monitoring of lung sounds provide a more accurate picture of respiratory health than episodic assessments?

In a 2022 publication in The Journal of Emergency Medicine, we reported findings from a study of 43 patients comparing continuous wheeze monitoring with the RESP® Biosensor to intermittent monitoring using an FDA-cleared electronic stethoscope. The RESP Biosensor not only captured more than four times as many wheezes, but also identified wheeze in a higher percentage of patients (85% vs. 78%).

These results highlight the potential of continuous monitoring to uncover important clinical insights that may be missed with traditional spot checks—helping clinicians and researchers gain a clearer, more complete view of respiratory health.

📄Read the publication: https://www.jem-journal.com/article/S0736-4679(22)00425-5/abstract